NUP98AML,MLL-Menin

Milad Rasouli1,2, Helen Blair3, Selina Troester4

  • 1Princess Maxima Center for pediatric Oncology, Utrecht, The Netherlands.

HemaSphere
|July 31, 2023
PubMed
概括

针对Menin-MLL与revumenib的相互作用抑制了NUP98融合的儿科急性髓性白血病 (AML). 这种Menin抑制剂疗法减少了白血病细胞的生长,并改善了临床前模型的结果.